Differing Outcomes Between Codon 12/13 and Codon 61 NRAS-Mutated Cancers in Patients With NRAS-Mutated Tumors Treated With Binimetinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase 2 NCI-MATCH Trial of Binimetinib in Patients With NRAS-Mutated Tumors
Clin. Cancer Res 2021 Feb 26;[EPub Ahead of Print], JM Cleary, VX Wang, RS Heist, S Kopetz, EP Mitchell, J Zweibel, KS Kapner, HX Chen, S Li, RJ Gray, LM McShane, L Rubinstein, D Patton, F Meric-Bernstam, MS Dillmon, PM Williams, SR Hamilton, B Conley, A Aguirre, PJ O'Dwyer, LN Harris, CL Arteaga, AP Chen, KT FlahertyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.